APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

25 hedge funds and large institutions have $3.25M invested in Aptose Biosciences, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SPC
1
Sigma Planning Corp
Michigan
$408K
2
AC
2
Annandale Capital
Texas
$209K
3
Citadel Advisors
3
Citadel Advisors
Florida
$48.6K
4
CA
4
Cetera Advisors
Colorado
$42K
5
Toronto Dominion Bank
5
Toronto Dominion Bank
Ontario, Canada
$12.9K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$0
2
VC
2
Voss Capital
Texas
$0
3
NCM
3
Nantahala Capital Management
Connecticut
$382K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$2K
5
Morgan Stanley
5
Morgan Stanley
New York
$131K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$8 -$125 -1 Closed
Fidelity International
27
Fidelity International
Bermuda
$4 – – –
National Bank of Canada
28
National Bank of Canada
Quebec, Canada
$3 -$5 – –
Goldman Sachs
29
Goldman Sachs
New York
– -$165K -1,182 Closed
VC
30
Voss Capital
Texas
– -$67.9K -488 Closed
1
2